About Genotropin Dosing

This content provides supplementary information for the Genotropin dose calculator, a tool designed to assist healthcare professionals in determining appropriate dosing schedules. Genotropin® is a brand of somatropin, a recombinant human growth hormone used to treat growth failure in pediatric patients and growth hormone deficiency (GHD) in adults. Dosing is highly individualized and depends on the specific indication, patient weight, and clinical response.

Calculator Outputs Explained

The calculator provides several key outputs to support proper administration:

• Total Weekly Dose (mg): The total amount of medication required over a full week, typically calculated as patient weight (kg) multiplied by the prescribed dose (mg/kg/week).
• Total Daily Dose (mg): The weekly dose divided by the number of injections per week (usually 6 or 7).
• Device-Specific Instruction: A practical administration guide based on the selected formulation, such as the volume to draw from a vial, the number of clicks for a GoQuick® pen, or the recommended strength for a MiniQuick® syringe.
• Body Surface Area (BSA): Calculated using the Mosteller formula if height and weight are provided. BSA can be a useful clinical parameter in assessing metabolic needs.

How to Use the Calculator

To ensure an accurate calculation, follow these steps:

1. Select Clinical Indication: Choose the appropriate FDA-approved indication from the dropdown menu (e.g., Pediatric GHD, Turner Syndrome, Adult Onset GHD). This determines the dosing type (weight-based vs. non-weight-based) and recommended ranges.
2. Enter Patient Weight: Input the patient's current weight and select the unit (kg or lbs). Weight is a critical factor for all pediatric dosing schedules.
3. Enter Prescribed Dose: For pediatric weight-based indications, enter the prescribed weekly dose in mg/kg/week. For adult non-weight-based indications, enter the starting daily dose in mg/day. The tool will pre-fill a default value based on the selected indication.
4. Select Device & Frequency: Choose the specific Genotropin® delivery device and the number of injections per week to receive a precise administration instruction.

Dosing Overview

Pediatric Dosing

For pediatric patients, dosing is typically weight-based and expressed in mg/kg/week. The dose is divided into 6 or 7 equal daily subcutaneous injections. The recommended dose range varies significantly by indication, with conditions like Small for Gestational Age (SGA) and Idiopathic Short Stature (ISS) potentially requiring higher doses than Growth Hormone Deficiency (GHD).

Adult Dosing

For adults with GHD, a non-weight-based approach is recommended. Therapy is initiated with a low starting dose (e.g., 0.15–0.3 mg/day) and titrated gradually based on clinical response and serum IGF-1 concentrations. Women, especially those on oral estrogen, may require higher doses than men.

Switching Between Somatropin Products

There are multiple brands of somatropin available. While they contain the same active molecule, they are not considered bioequivalent and may have different formulations or delivery devices. When switching a patient from another somatropin product to Genotropin®, careful dose re-evaluation and clinical monitoring are essential. It is not appropriate to assume a 1:1 dose conversion. All switching should be managed by a clinician experienced in growth hormone therapy.

Missed Dose Instructions

If a dose of Genotropin® is missed, the patient or caregiver should be instructed to administer it as soon as it is remembered. However, they should not take two doses on the same day to make up for a missed one. The regular dosing schedule should be resumed on the following day. Consistently missing doses can reduce the efficacy of the treatment.

Safety Alerts

Genotropin® is contraindicated in patients with acute critical illness, active malignancy, diabetic retinopathy, or known hypersensitivity. Treatment should be used with caution in patients with a history of intracranial lesions, diabetes mellitus, or scoliosis. Key adverse reactions include injection site reactions, fluid retention (edema), glucose intolerance, and intracranial hypertension. Refer to the full prescribing information for a complete list of warnings and precautions.

Frequently Asked Questions

1. Why does the calculator use both weight-based and non-weight-based dosing?
   This reflects the approved dosing strategies. Pediatric indications rely on weight-based dosing (mg/kg/week) for growth, while adult GHD treatment uses a non-weight-based approach with titration based on individual response and IGF-1 levels.
2. How does the calculator recommend a MiniQuick® dose?
   The calculator determines the ideal daily dose in mg, then selects the closest available pre-filled MiniQuick® syringe strength (e.g., 0.2, 0.4, 0.6 mg). This may require clinical judgment to adjust further.
3. What is the difference in dosing for Adult Onset vs. Childhood Onset GHD?
   Adults with Childhood Onset GHD who are continuing therapy may require higher maintenance doses than those with Adult Onset GHD. The calculator provides different default starting dose ranges for each group.
4. Can I use this calculator for other brands of somatropin?
   No. This calculator is designed specifically for Genotropin® formulations and devices (GoQuick®, MiniQuick®). Dosing clicks, concentrations, and available strengths are specific to this brand.
5. Why is the dose flagged as outside the typical range?
   The tool contains pre-programmed FDA-approved dosing ranges for each indication. If the entered dose is lower or higher than this range, a warning appears to prompt verification of the prescription.
6. Is the Body Surface Area (BSA) calculation required?
   No, providing height to calculate BSA is optional. While pediatric dosing is weight-based, some clinicians use BSA as an additional metric for assessing patient parameters.
7. How are the "clicks" for the GoQuick® pen determined?
   Each GoQuick® pen (5 mg or 12 mg) is designed to deliver a specific dose per click. The calculator divides the required daily dose (mg) by the mg-per-click value for the selected pen to determine the number of clicks.
8. Why are there options for 6 or 7 injections per week?
   While daily (7/week) administration is common, the prescribing information allows for dividing the total weekly dose over 6 injections to provide a day off, which may improve adherence for some patients.

References

1. GENOTROPIN (somatropin) for injection, Prescribing Information. U.S. Food and Drug Administration. Pfizer Inc. Revised: 01/2020.
2. Genotropin® Official Healthcare Professional Website. Pfizer Inc. Accessed October 2023.
3. Drugs@FDA: GENOTROPIN (somatropin). U.S. Food and Drug Administration.
4. Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr. 2016;86(6):361-397.